Bottom line
JSIGX vs VBK: the short answer
JSIGX (Jacob Small Cap Growth Fund) and VBK (Vanguard Small-Cap Growth Index Fund) are both mutual funds.
But VBK is far broader, holding 553 positions to 33 for JSIGX, so beyond the top names it adds exposure JSIGX doesn't have.
VBK is cheaper at 0.05% vs 2.96% — a difference of $291 a year per $10,000 invested.
Over five years, VBK returned +3.0% a year vs −1.1% for JSIGX (reporting dates differ).
Updated Nov 19, 2026
JSIGX vs VBK side by side
| JSIGX | VBK | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Jacob | Vanguard |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 2.96% | 0.05% |
| Annual cost per $10k | $296 | $5 |
| 10-yr cost on $10k (prospectus) | $3,954 | $64 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +42.0% | +8.4% |
| 5-yr return (annualized) | −1.1% | +3.0% |
| 10-yr return (annualized) | +10.0% | +10.3% |
| Best quarter | — | +32.9% |
| Worst quarter | — | −24.2% |
| Net assets (fund) | $8.3M | $47.0B |
| Number of holdings | 33 | 553 |
| Portfolio turnover | 58% | 24% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
JSIGX and VBK share none of their top holdings.
JSIGX top 10
- First American Government Obli — 8.21%
- Celcuity Inc — 6.90%
- Circle Internet Group Inc — 5.05%
- Alphatec Holdings Inc — 4.93%
- Beam Therapeutics Inc — 4.85%
- Omeros Corp — 4.80%
- Harrow Inc — 4.64%
- Codexis Inc — 4.52%
- DraftKings Inc — 4.20%
- Powerfleet Inc NJ — 4.18%
VBK top 10
- Vanguard Cmt Funds-Vanguard Market Liquidity Fund — 2.55%
- Credo Technology Group Holding Ltd — 1.27%
- REVOLUTION Medicines Inc — 1.06%
- Astera Labs Inc — 1.05%
- Natera Inc — 1.04%
- Twilio Inc — 0.88%
- Casey's General Stores Inc — 0.83%
- Carpenter Technology Corp — 0.82%
- Curtiss-Wright Corp — 0.79%
- FTAI Aviation Ltd — 0.78%
FAQ
What is the difference between JSIGX and VBK?
Which is cheaper, JSIGX or VBK?
Should I own both JSIGX and VBK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.